|
Market Closed -
Nasdaq
16:00:00 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 586.48 USD | -0.80% |
|
+4.08% | +20.37% |
| 10-28 | United Therapeutics Insider Sold Shares Worth $5,583,418, According to a Recent SEC Filing | MT |
| 10-28 | United Therapeutics Wins FDA Clearance for Treprostinil-Iloprost Phase 1 Trial | MT |
Stock exchange
Nasdaq
UTHR 586.48 $
-0.80%
247M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| UTHR | 586.48USD | -0.80% | 247M $ | ||
CBOE
| UTHR | 585.84USD | -0.87% | 7.04M $ | |
|
Boerse Muenchen
| UTH | 524.60EUR | -1.06% | 524.6 € | |
|
Deutsche Boerse AG
| UTH | 526.80EUR | +0.19% | 0 € | |
|
Tradegate
| UTH | 525.40EUR | -1.09% | 0 € | |
|
Börse Stuttgart
| UTH | 524.00EUR | -0.98% | 0 € | |
|
Berne S.E.
| UTH | 485.01CHF | +0.17% | 0 CHF | |
|
Xetra
| UTH | 525.40EUR | 0.00% | 0 € | |
| U2TH34 | 157.10BRL | -3.32% | 31.42K R$ |
Quotes 5-day view: United Therapeutics Corporation
Delayed Quote Nasdaq
| 2026-10-22 | 2026-10-23 | 2026-10-26 | 2026-10-27 | 2026-10-28 | |
|---|---|---|---|---|---|
| Last | US$584.79 | US$587.50 | US$592.84 | US$591.20 | US$586.30 |
| Volume | 895,458 | 637,875 | 577,007 | 457,446 | 402,484 |
| Change | +3.78% | +0.46% | +0.91% | -0.28% | -0.83% |
| Opening | US$568.69 | US$584.92 | US$589.11 | US$587.10 | US$581.94 |
| High | US$590.79 | US$590.98 | US$593.50 | US$593.00 | US$589.19 |
| Low | US$562.86 | US$576.24 | US$584.50 | US$582.67 | US$581.88 |
Performance
| 1 day | -0.80% | ||
| 1 week | +4.08% | ||
| Current month | +8.23% | ||
| 1 month | +20.79% | ||
| 3 months | +12.00% | ||
| 6 months | +3.05% | ||
| Current year | +20.37% | ||
| 1 year | +41.20% | ||
| 3 years | +167.52% | ||
| 5 years | +205.19% | ||
| 10 years | +396.43% |
Volumes
marketsDaily volume
421,674
Estimated daily volume
421,674
Avg. Volume 20 sessions
747,642
Daily volume ratio
0.56
Avg. Volume 20 sessions USD
438,477,080.16
Record volume 1
29,067,760
Record volume 2
17,493,640
Record volume 3
14,409,470
Capital turnover ratio
0.02
Float rotation
0.02
Basic data
Market Cap (USD)
25,356,977,110
Net sales (USD)
3,182,700,000
Number of employees
1,400
Sales / Employee (USD)
2,273,357
Free-Float
53.72%
Free-Float capitalization (USD)
24,849,087,832
Average Daily Capital Traded
1.73%
Indicators
Moving average 5 days
583.96
Moving average 20 days
548.76
Moving average 50 days
521.24
Moving average 100 days
529.08
Price spread / (MMA5)
-0.43%
Price spread / (MMA20)
-6.43%
Price spread / (MMA50)
-11.12%
Price spread / (MMA100)
-9.79%
STIM
RSI 9 days
76.49
RSI 14 days
70.4
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.80% | +4.08% | +41.20% | +167.52% | 25.36B | |
| +0.50% | +1.38% | +57.09% | +129.96% | 1,143B | |
| +0.86% | +5.14% | +45.00% | +86.15% | 647B | |
| -0.14% | +0.42% | +25.69% | +105.85% | 506B | |
| -0.05% | +2.28% | +49.14% | +67.74% | 384B | |
| -0.63% | -5.97% | +61.93% | +37.06% | 350B | |
| +0.34% | +2.15% | +25.26% | +54.27% | 293B | |
| -0.45% | +1.16% | +1.74% | +26.08% | 265B | |
| +0.87% | +3.08% | +54.69% | +72.74% | 242B | |
| +0.08% | +3.67% | +35.05% | +107.78% | 197B | |
| Average | +0.23% | +1.44% | +39.68% | +85.52% | 405.29B | |
| Weighted average by Cap. | +0.48% | +0.74% | +43.67% | +89.51% |
Historical Quotes: United Therapeutics Corporation
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
fb94be5b22afe67c2d47bb8c.9-NoZGK4x19o6nCG4Pn_EOTDf1SBURYfmxQsFyr3GBI.vaELViCIpGsBmBPsp8y4I5LyLD3UHkBvtlBCInrOS2K5kj00U--DMjmNAw
| Date | Price | Volume | Total |
|---|---|---|---|
| 16:00:00 | 586.48 | 82,012 | 271,534 |
| 15:59:59 | 586.30 | 83 | 189,522 |
| 15:59:59 | 586.52 | 40 | 189,439 |
| 15:59:58 | 586.46 | 55 | 189,399 |
| 15:59:57 | 586.52 | 40 | 189,344 |
| 15:59:57 | 586.56 | 40 | 189,304 |
| 15:59:56 | 586.44 | 80 | 189,264 |
| 15:59:56 | 586.44 | 80 | 189,184 |
| 15:59:55 | 586.56 | 40 | 189,104 |
| 15:59:55 | 586.56 | 40 | 189,064 |
Price Extremes
| 1 week | 576.24 |  | 593.5 |
| 1 month | 475.46 | | 593.5 |
| Current year | 455.63 | | 609.35 |
| 1 year | 430.02 | | 609.35 |
| 3 years | 208.62 | | 609.35 |
| 5 years | 158.38 | | 609.35 |
| 10 years | 74.31 | | 609.35 |
Monthly variations
Annual variations
| 2026 | +20.33% | ||
| 2025 | +38.09% | ||
| 2024 | +60.46% | ||
| 2023 | -20.93% | ||
| 2022 | +28.70% | ||
| 2021 | +42.35% | ||
| 2020 | +72.33% | ||
| 2019 | -19.12% | ||
| 2018 | -26.39% | ||
| 2017 | +3.15% | ||
| 2016 | -8.42% | ||
| 2015 | +20.94% | ||
| 2014 | +14.51% | ||
| 2013 | +111.68% | ||
| 2012 | +13.06% | ||
| 2011 | -25.26% | ||
| 2010 | +20.08% | ||
| 2009 | +68.35% | ||
| 2008 | -35.94% | ||
| 2007 | +79.60% | ||
| 2006 | -21.34% | ||
| 2005 | +53.09% | ||
| 2004 | +96.73% | ||
| 2003 | +37.43% | ||
| 2002 | +60.42% | ||
| 2001 | -29.42% | ||
| 2000 | -67.93% | ||
| 1999 | +277.44% |
- Stock Market
- Stocks
- UTHR Stock
- Quotes United Therapeutics Corporation
Select your edition
All financial news and data tailored to specific country editions
